텔미트렌정, 텔미누보정, 텔미트렌에스정, 텔미로젯정, 누보로젯정 [종근당]
텔미트렌 : telmisartan : 20 mg, 40 mg, 80 mg ★20 mg 용량이 있음 텔미누보 : telmisartan/S-amlodipine : 40/2.5 mg, 40/5 mg, 80/2.5 mg, 80/5 mg 텔미트렌에스 : telmisartan/rosuvastatin : 40/5 mg, 40/10 mg, 80/10 mg, 80/20 mg 텔미로젯 : telmisartan/rosuvastatin/ezetimibe : 40/5/10 mg, 40/10/10 mg, 40/20/10 mg 누보로젯 : telmisartan/S-amlodipine/rosuvastatin/ezetimibe : 40/2.5/5/10 mg, 40/2.5/10/10 mg, 40/5/5/10 mg, 40/5/10/1..
심박출 감소 심부전 (HFrEF)에서 가이드라인에 근거한 치료와 SGLT2i에 대한 내용 (해리슨 21판, 2022 AHA/ACC/HFSA Guideline, UpToDate)
해리슨 21판 Guideline-directed pharmacologic therpay ACEI - lisinopril, enalapril, captopril, trandolapril ARB - losartan, valsartan, candesartan Aldosterone antagonists - eplerenone, spironolactone Beta blockers - metoprolol succinate CR/XL, carvedilol, bisoprolol Arteriovenous vasodilators - hydralazine isosorbide dinitrate, fixed-dose hydralazine/isosorbide dinitrate Angiotensin receptor-neprilys..